Mutations in the human factor XII gene

Blood

Volumn 90, Issue 10, 1997, Pages 3967-3977

  Schloesser, Manfred ^a   Zeerleder, Sacha ^b   Lutze, Gerd ^b   Halbmayer, Walter Michael ^b   Hofferbert, Sigrun ^b   Hinney, Bernd ^b   Koestering, Heinz ^b   Lämmle, Bernhard ^b   Pindur, Gerhard ^b   Thies, Karsten ^b   Köhler, Michael ^b   Engel, Wolfgang ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; BLOOD CLOTTING FACTOR 12; GLUTAMINE; LEUCINE; METHIONINE;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; BASE PAIRING; BLOOD CLOTTING DISORDER; CHROMOSOME 5Q; FIBRIN CLOT; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; INTRON; MISSENSE MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALLELES; EUROPE; FACTOR XII; FEMALE; GENOME, HUMAN; HUMANS; MALE; MUTATION; PEDIGREE;

EID: 0030812723     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fuhrer G, Gallimore MJ, Heller W, Hoffmeister HE: FXII. Blut 61:258, 1990
2. Wachtfogel Y, DeLa Cadena RA, Colman RW: Structural biology cellular interactions and pathophysiology of the contact system. Thromb Res 72:1, 1993
3. Miyata T, Kawabata SI, Iwanaga S, Takahashi I, Alving B, Saito H: Coagulation factor XII (Hageman factor) Washington D.C.: Inactive factor XIIa results from Cys-571-Ser substitution. Proc Natl Acad Sci USA 86:8319, 1989
4. Kremer Hovinga J, Schaller J, Stricker H, Wuillemin WA, Furlan M, Lämmle B: Coagulation factor XII Locarno: The functional defect is caused by the amino acid substitution Arg 353 → Pro leading to loss of a kallikrein cleavage site. Blood 84:1173, 1994
5. Cool DE, Edgell CJ, Louie GV, Zoller MJ, Brayer GD, MacGillivray RT: Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa. J Biol Chem 260:13666, 1985
6. Tripodi M, Citarella F, Guida S, Galeffi P, Fantoni A, Cortese R: cDNA sequence coding for human coagulation factor XII (Hageman). Nucleic Acids Res 13:3146, 1986
7. Cool DE, MacGillivray RTA: Characterization of the human blood coagulation factor XII gene: Intron/exon gene organization and analysis of the 5-prime flanking region. J Biol Chem 262:13662, 1987
8. Royle NJ, Nigli M, Cool D, MacGillivray, Hamerton JL: Structural gene encoding human FXII is located at 5q33-qter. Somatic Cell Mol Genet 14:217, 1988
9. Bernardi F, Marchetti G, Patracchini P, del Senno L, Tripodi N, Fantoni A, Bariolai S, Vannini F, Felloni L, Rossi L, Panicucchi F, Conconi F: Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme. Blood 69:1421, 1987
10. Hofferbert S, Müller J, Köstering H, von Ohlen WD, Schloesser M: A novel 5′upstream mutation in the factor XII gene is associated with a TaqI restriction site in an Alu repeat in factor XII-deficient patients. Hum Genet 97:838, 1996
11. Schloesser M, Hofferbert S, Bartz U, Lutze G, Lämmle B, Engel W: The novel acceptor splice site mutation 11396(G → A) in the factor XII gene causes a truncated transcript in cross-reacting material negative patients. Hum Mol Genet 4:1235, 1995
12. Schloesser M, Arleth S, Lenz U, Bertele RM, Reiss J: A cystic fibrosis patient with the nonsense mutation G542X and the splice site mutation 1717-1. J Med Genet 28:878, 1991
13. Braulke I, Pruggmayer M, Melloh P, Hinney B, Koestering H, Guenther E: Factor XII (Hageman) deficiency in women with habitual abortion: A new subpopulation of recurrent aborters? Fertil Steril 59:98, 1993
14. Lutze G, Breyer J, Zawta B: Useful Facts about Coagulation. Boehringer, Germany, Boehringer Mannhein GmbH, 1996
15. Lämmle B, Wuillemin WA, Huber I, Krauskopf M, Zürcher C, Pflugshaupt R, Furlan M: Thromboembolism and bleeding tendency in congenital factor XII deficiency - A study on 74 subjects from 14 Swiss families. Thromb Haemost 65:117, 1991
16. Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M: The prevalence of factor XII deficiency in 103 anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. Thromb Haemost 68:285, 1992
17. Kemptner B, Rueth S, Epple I, Lohse P: Untersuchungen zur Genetik des Faktor-XII-Mangels, in Kretschmer V, Stangel W, Eckstein R (eds): Beitr Infusionsther: 31. Freiburg, Germany, Karger, 1993, p 174
18. Krawczak M, Reiss J, Cooper DN: The mutational spectrum of single base-pair substitutions in mRNA splice site junctions of human genes: Causes and consequences. Hum Genet 90:41, 1992
19. Sprang S, Standing T, Fletterick RJ, Stroud RM, Finer-Moore J, Xuong NH, Hamlin R, Rutter WJ, Craik CS: The three-dimensional structure of Asn102 mutant of trypsin: Role of Asp102 in serine protease catalysis. Science 237:905, 1987
20. Semba U, Yamamoto T, Kunisada T, Shibuya Y, Tanase S, Kambara T, Okabe H: Primary structure of guinea-pig Hageman factor: Sequence around the cleavage site differs from the human molecule. Biochim Biophys Acta 1159:113, 1992
21. Shibuya Y, Semba U, Okabe H, Kambara T, Yamamoto T: Primary structure of bovine Hageman factor (blood coagulation factor XII): Comparison with human and guinea pig molecules. Biochem Biophys Acta 1206:63, 1994
22. Kratzschmar J, Haendler B, Langer G, Boidol W, Bringmann P, Alagon A, Donner P, Schleuning WD: The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: Cloning and expression. Gene 105:229, 1991
23. Huerou L, Wicker C, Guilloteau P, Toullec R, Puigserver A: Isolation and nucleotide sequence of cDNA clone for bovine pancreatic anionic trypsinogen. Structural identity within the trypsin family. Eur J Biochem 193:767, 1990
24. Shirasu Y, Yoshida H, Mikayama T, Matsuki S, Tanaka J, Ikenaga H: Isolation and expression in Escherichia coli of a cDNA clone encoding porcine pancreatic elastase. J Biochem 99:1707, 1986
25. Cohen GH, Silverton EW, Davies DR: Refined crystal structure of gamma chymotrypsin at 1.9 A resolution. Comparison with other pancreatic serine proteases. J Mol Biol 148:449, 1981
26. Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, Bennett WF, Yelverton E, Seeburg PH, Heyneker HL, Goeddel DV, Collen D: Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301:214, 1983
27. Kunnath-Muglia LM, Chang GH, Sim RB, Day AJ, Ezekowitz RA: Characterization of Xenopus laevis complement factor I structure - Conservation of modular structure except for an unusual insert not present in human factor I. Mol Immunol 30:1249, 1993
28. Catterall CF, Lyons A, Sim RB, Day AJ, Harris TJ: Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones. Biochem J 242:849, 1987
29. Pearson PL, van der Kamp J, Veltkamp J: Reduced Hageman factor level in a 6p- patient. Cytogenet Cell Genet 32:309, 1982
30. Vansant G, Reynolds WF: The consensus sequence of a major Alu subfamily contains a functional retinoic acid response element. Proc Natl Acad Sci USA 92:8229, 1995
31. Fersht A: Enzyme Structure and Mechanism. New York, NY, Freeman, 1977
32. Konvalinka J, Litterst MA, Welker R, Kottier H, Rippmann F, Heuser AM, Krausslich HG: An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J Virol 69:7180, 1995
33. Craik CS, Roczniak S, Largman C, Rutter WJ: The catalytical role of the active site aspartic acid in serine proteases. Science 237:909, 1987
34. Henderson BR, Tansey WP, Phillips SM, Ramshaw IA, Kefford RF: Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells. Cancer Res 52:2489, 1992
35. Pinsky SD, LaForge KS, Scheele G: Differential regulation of trypsinogen mRNA translation: Full-length mRNA sequences encoding two oppositely charged trypsinogen isoenzymes in the dog pancreas. Mol Cell Biol 5:2669, 1985
36. Goodnough LT, Saito M, Radnoff OD: Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) 62:248, 1983
37. Mannhalter C, Fischer M, Hopmeier P, Deutsch E: Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis. Fibrinolysis 1:259, 1987
38. von Känel R, Wuillemin WA, Furlan M, Lämmle B: Factor XII clotting activity and antigen levels in patients with thromboembolic disease. Blood Coagul Fibrinolysis 3:555, 1992
39. Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
40. Koster T, Rosendaal FR, Briet E, Vandenbroucke JP: John Hageman's factor and deep-vein thrombosis: Leiden Thrombophilia Study. Br J Haematol 87:422, 1994